Clinical Trials
3 trialsNCT04165096 2026-05-13
MK-3475-01C
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT03554473 2025-05-09
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT04237090 2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3 Completed